Key Points President Trump's tariffs could erode healthcare companies' profits, but some may perform well regardless.Eli Lilly and Novartis have taken steps to mitigate the potential impact. Both ...

Analysts still expect a solid second quarter from Alphabet. But others say AI technology now poses a deeper threat to ...

Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.

The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...

Trump told reporters last week that he had talks with Congress members of removing the Central Bank Chair, during which he ...

With no price-moving triggers visible currently—think tariffs, fresh wars—and earnings mostly in line with expectations, ...